Heterogeneity of intratumoral 111In-ibritumomab tiuxetan and 18F-FDG distribution in association with therapeutic response in radioimmunotherapy for B-cell non-Hodgkin’s lymphoma
暂无分享,去创建一个
K. Ishii | I. Matsumura | Kohei Hanaoka | Kenta Sakaguchi | M. Hosono | Sung-woon Im | Y. Tatsumi | N. Tsuchiya